what can we expect from the cdc advisory panel meeting to talk about that shot today. >>> a new roof and faculty risk returning this fall. >>> the worriers return to the chase and to and for the first time in a long time, they will be playing in front of actual fans tonight. the new protocols. good morning. >>-friday, friend. >> this ensemble, i love it. >> let me show you this part. >> please do. spring has sprung! [ laughter ] glad to see all of you, thanks for being here today. >>> we will start with that johnson & johnson vaccine. cdc officials will decide the future of the vaccine and determine if it is still safe

romaine: we were awaiting word on the cdc advisory panel, reaffirming the vaccine for johnson & johnsonis is an advisory, of cdc. you still need a final signoff by cdc as well as fda. usually the advisory panel's word is followed by the full agency. caroline: europe has already welcomed back johnson & johnson shots. after hours at .8%. that does it for "what'd you miss?" romaine: have a great weekend, this is bloomberg. ♪ want to save hundreds on your wireless bill? with xfinity mobile, you can. how about saving hundreds on the new samsung galaxy s21 ultra 5g? you can do that too. all on the most reliable network? sure thing! and with fast, nationwide 5g included - at no extra cost? we've got you covered. so join the carrier rated #1 in customer satisfaction... ...and learn how much you can save at xfinitymobile.com/mysavings. so many people are overweight now and asking themselves, "why can't i lose weight?" for most, the reason is insulin resistance, and they don't even know they have it. conventional starvation diets don't address insulin resistance. that's why they don't work. now t

and as for the johnson & johnson vaccine, the cdc advisory panel is hoping to make a decision within the next ten days. mona. >> faith, thank you. >>> the biden administration is expected to announce new sanctions against russia today. the new financial penalties are retaliation for russian cyberattacks that breached several government agencies as well as the kremlin's interference in the u.s. election. similar punitive measures by the u.s. in the past have failed to stop russian aggression. >>> cia director william burns has delivered a sobering message to congress just as president biden announces plans to withdraw troops from afghanistan by september 11th. burns told lawmakers once the troops leave, our ability to collect intelligence in afghanistan and act on threats will diminish, but the president says it's time to end our longest war. >> we delivered justice to bin laden a decade ago, and we've stayed in afghanistan for a decade since. since then our reasons for remaining in afghanistan become increasingly unclear. >> defense secretary lloyd austin defended biden's decision sa

friday health experts on the cdc advisory panel recommended the johnson and johnson vaccine.return. >> with a warning about the risk of where blood clot, the janssen covid vaccine is recommended for person sorry, 18 years of age and older in the u.s. population. >> under the fda's emergency use authorization. >> in the meantime, the white house says it's planning to step up its effort to get millions of more people vaccinated. we have less of a supply we have more of a. it's incumbent upon us to reach people in need them where they are. we are laser focused on educating the public at a white house covid response briefing friday lead coordinator. jeffrey zients seemingly acknowledged after weeks of steady vaccination. daily numbers. the nation saw a recent dip going forward. we expect daily vaccination rates will moderat

a cdc advisory panel set to meet this morning to weigh in on the johnson & johnson vaccine.u know it has been on hold after six women developed rare blood clots. >> the cdc says it is also looking into new mask guidelines. we're going to get into that with nih director dr. francis collins, but first steve osunsami starts us off at cdc headquarters in atlanta. good morning, steve. >> reporter: good morning to you, michael. the health officials here who are making this decision today are in a tough spot, trying to put safety first but at the same time trying not to scare americans away from using these vaccines. today is the day a panel of experts put together by the cdc is expected to decide whether people should keep using the single dose johnson & johnson covid vaccine. it's a key tool in ending the pandemic, but u.s. health officials put use of the vaccine on hold last week when six women got sick with rare blood clots after getting the shot and this morning, the cdc says it's investigating a handful of new cases. 18-year-old emma burkey from clark county, nevada, is one o

what can we expect from the cdc advisory panel meeting to talk about that shot today. >>> a new roof for students, staff and faculty risk returning this fall. >>> the worriers return to the chase and to and for the first time in a long time, they will be playing in front of actual fans tonight. the new protocols. good morning. >>-friday, friend. >> this ensemble, i love it. >> let me show you this part. >> please do. spring has sprung! [ laughter ] glad to see all of you, thanks for being here today. >>> we will start with that johnson & johnson vaccine. cdc officials will decide the future of the vaccine and determine if it is still safe for americans to continue receiving that one shot as the nation is experiencing a slowdown of vaccinations being fueled by people who are hesitant about vaccines in general. >> good morning. 7 million doses have already been administered when officials made the decision to pause the mandatory vaccine after individuals developed an extremely rare blood clot. >> it looks like we will get back to that in just a moment. >>> first, i want to tell you abo

the cdc advisory panel meets at amr time a decision is inspected to be made before the date is over. >>> part of today's hearing is going to include discussion about the case of an organ woman who died two weeks after getting the j&j vaccine. the cdc cafe if that death is related to the vaccine, until it completes an investigation. now in texas, another investigation is underway, every woman there was admitted to the hospital after getting the j&j j&j j&j j&j health officials there say her symptoms, quote, appear to be consistent with those few other reported cases. >>> california may have turned the tide on the pandemic. the state has gone from having the highest case count, after the holidays, to now having the lowest in the nation. this is according to data compiled by johns hopkins university. during the winter surge, we were seeing 40,000 new covid cases every day. more than 500 people were dying every day. those numbers have now dropped to just 2300 daily cases, and 68 deaths. >>> the warriors are taking on the denver nuggets at chase center tonight for the first time this seas

. >> reporter: with the cdc advisory panel vote, and the blessing of some of the health officials of country, the johnson & johnson vaccine is back. . >> this is not a decision the agency has reached lightly. >> reporter: on pause for 10 days after a reports of a handful of blood clots and several deaths out of 7 million doses doled out. >> the american public should feel reassured about the safety systems and protocols that we have in place. >> reporter: cdc director rochelle walensky laying out a total of 15 cases severe blood clots and low platelets. all affected were women, 18 to 59, with symptoms starting 15 days from vaccination. thraoel deaths occurred with seven women still hospitalized. that includes 18-year-old emma burki, who is out of a coma and on the road to recovery. >> she has been improving slowly and steadily. >> reporter: dr. walensky providing a window into the benefits of bringing j&j back. >> for every 1 million doses of this vaccine, the j&j vaccine could prevent over 650 hospitalizations and 12 deaths among women age 18 to 49. >> reporter: for older women, tho

that's on top of the cdc advisory panel pushing -- advisory panels pushing off a decision on the johnsonter it was put on pause over concerns of rare cases of blood clotting issues. joining me right now is dr. lina wen. she is former baltimore health commissioner and author of "life line: a doctor's journey in the fight for public health." good to see you, doctor. let's start with the booster shot that the pfizer ceo was just talking about. does the need for a booster shot surprise you? and does it say anything about the effectiveness of the vaccines? >> it's not surprising at all. we've been saying that all along. the effectiveness of the immunity may wain over time, decrease over time. getting the booster might increase the immune protection. the other reason is we have these variants that remerging. we may need booster that's specifically target new strains that may evade the effectiveness of the existing vaccine. and so it's not surprising. i actually think that people should see this as a good thing. as in science is evolving and we're going to be giving people the best immune prote

we're learning new details of the vote by a cdc advisory panel.ams in conventional thinking. it didn't get us to the moon. it doesn't ring the bell on wall street. or disrupt the status quo. t-mobile for business uses unconventional thinking to help you realize new possibilities. like our new work from anywhere solutions, so your teams can collaborate almost anywhere. plus customer experience that finds solutions in the moment. ...and first-class benefits, like 5g with every plan. network, support and value without any tradeoffs. that's t-mobile for business. zero-commission trades for online u.s. stocks and etfs. and a commitment to get you the best price on every trade, which saved investors over $1.5 billion last year. that's decision tech. only from fidelity. dignity. it demands a rapid covid test, because we all deserve an answer. it demands a better understanding of your glucose levels, so you can enjoy movie night. and knowing your baby is getting the nutrition he needs, no matter how you choose to feed him. at abbott, we fight for these mo

johnson & johnson kobe vaccine appears to be on the verge of being given out once again after a cdc advisory panel to do so and provide a warning. before the panel's recommendation, i spoke today with dr. fauci, the director of the national institute of allergy and infectious diseases. he is also the chief medical advisor to president biden. we should note that johnson & johnson is a funder of the newshour. thank you for joining us. you and i are recording this interview before we know what the cdc is going to say today about whether to reauthorize the use of the johnson & johnson vaccine, but whatever their decision is, how much of a setback to the overall efforts to get vaccine into as many arms as possible as this pause been in? dr. fauci: i do not think it has been significant, particularly since if they make the decision to go back out there and get this vaccine back in play, i think you will see people who are wanting to get this particular vaccine will be lining up to get it. i think the pause, although for a period of time, some people felt that was going to diminish the confidence in the

. >> a cdc advisory panel has just ruled that the johnson and johnson vaccine should return. it's been 11 days since it was paused due to a very rare blood clot that was found specifically in women raquel martin joining us live now with the latest from washington. raquel, what can you tell us about how the panel voted today and how soon we could see this shot. being administered again. >> well, this afternoon we saw the cdc panel vote 10 to 4 to recommend the use of that johnson and johnson vaccine. but we know this isn't the end of the road. that is not a binding agreement. we know we have to wait for the cdc director to act next. she says she wants to move quickly. friday, health experts on the cdc advisory panel recommended the johnson and johnson vaccine. should return with a warning about the risk of where blood clot. the janssen covid vaccine is recommended for person 100 18 years of age and older in the u.s. population. >> under the fda's emergency use authorization. >> in the meantime, the white house says it's planning to step up its effort to get millions of more pe

on friday a cdc advisory panel is expected to do the same. the warning will include recommendations about who may be best suited to take the single dose shot. it was paused after reports of rare lead class. however, experts say the benefits outweigh the risks. >>> santa clara county is sending outreach teams door to door to try to reach people who might be hesitant to get the shot. they are hoping to combat misinformation and help people book appointments. right now, just under 60% of the population is at least partially vaccinated. >>> the pandemic didn't stop 4/20 celebrations across the bay area, even if it meant getting a little creative. >> maria medina is in san jose with why this year's unofficial cannabis holiday will be remembered more than others. to make this year people were eager to gather for 4/20 even if it meant virtually or in small grounds. after all, all the celebrations were shut down last year due to covid. this area in san jose dubbed the spark. including those who came to san jose after finding their usual 4/28 hangouts

he's on the cdc advisory panel. the panel voted 10-4 with one abstaining to allow the johnson & johnson to be administered again. you were one of the ten to end the pause. how and why did you and your other colleagues on this panel come to that decision? >> we really felt very strongly that the process had played out rather impressively. it's amazing how the nation's vaccine safety surveillance system identified this signal, which prompted further investigation of the cases. an extensive investigation was done that identified these 15 cases in women, and we felt that it was important for the j&j vaccine to be reinstituted so we could have three covid-19 vaccines because of the significant morbidity and mortality associated with covid-19. it is important, though, that there's a warning and that details around the possibility of blood clots and low platelets is conveyed both to providers so they manage these cases well, but also to people receiving the vaccine. >> so the question a lot of people are having this mornin

on friday the cdc advisory panel is expected to do the same. the warning will include recommendations about who may be best suited to take that single dose shot. the vaccine was paused after reports of rare blood clots but experts say the benefits out weigh the risks. >>> meantime there's a new push in santa clara county. >> i will take it from here. there's a push to vaccinate those who may hesitate to get a shot. people are going door to door, hoping to help people book appointments. just under 60% is at least partially vaccinated. county health officials say they need to raise that number significantly to reach herd immunity. >>> last night the marin water district voted to go head with new restrictions on water use. the water board's vote came after nearly five hours of public comment. this is the first time in years that the county has issued such restrictions. this as reservoirs are seeing very low levels. >> driest year inve had, you q ount oflk rand e water see what the situation is. >> the new rules limit unnecessary use of water like

. >>> coming up, ac/dc advisory panel on the future of the johnson & johnson vaccine as we learn new 45- year-old woman who died shortly after her j&j vaccines. that is all coming up on the news. >>> the giants win the game but lose an ace. >> those will be shoes difficult to fill. when he goes to dinner he the giants are off to the best start. and it has the second lowest e.r.a. in the national league and doing his best and johnny with a shimmy and they held the reds scoreless over 5 and two thirds and he was stealing in the game scoreless with the bottom of the 5th and slater goes the other way and 0-2 pitch and crawford hustles for home and the giants take a 1-0 lead and slater is turning the heat up which is good news for the giants. and picked up the fourth strikeout but signaled to the dugout right away that something wasn't right and left the game with tightness on the going. in the top nine automatic mcgee with another scoreless inning got the strikeout to end it for six games in the giants beat the reds 3-0 and they finish 5- 1. >> i think it is important that we write out t

i know you're on the fda advisory panel that will offer a recommendation.ve any concerns at least preliminarily about this request? >> first of all, i'm not sure that necessarily comes from our committee, the fda advisory committee. the top line data look very good. it was a study of about 2,200 children who did or didn't get that vaccine. there were 18 cases of covid-19 all in the placebo group. the vaccine appeared to be safe plus, frankly, you wouldn't expect there to be much of a difference in the 12 to 15-year-old as compared to the 16 to 18-year-old for whom that vaccine is already approved, so i'm optimistic that the top line data are exactly what they appear to be, and we need vaccines for children because children can certainly be hurt by this virus. >> dr. offit, thank you very much. always great to see you on a saturday morning, thank you. >> thank you. >> whit, over to you. >> dan, we turn to politics. and president biden releasing details of his $1.5 trillion budget proposal boosting spending for education, public health and fighting climate ch

the pause on the johnson and johnson vaccine officially lifted friday after a cdc advisory panel decided the benefits far outweigh the risks. the decision comes ten days after reports of a happened full of severe but rare blood clotting conditions called thrombosed apena syndrome where blood clots form in the legs, lungs or the brain. >> the risk to women is definitely there, but it's extremely low. but there are other vaccines if people feel that's a concern, and certainly for women over 50 the risk is extremely low. >> reporter: the infectious disease specialist believes providing a list of risks to vaccine recipients is sufficient. >> we dealt with it the seam way and that's severe as well. and the risk here is just about the same. >> reporter: of the nearly 8 million johnon and johnson doses administered in the u.s., there have been 15 blood clotting cases identified in women, mainly under the age of 50. only two women were older than 50. of the 15 cases, 12 why linked to cvst indicating blood clots were found in the brain. seven women are still being hospitalized, and three have die

friday health experts on the cdc advisory panel recommended the johnson and johnson vaccine. should return. >> with a warning about the risk of where blood clot, the janssen covid vaccine is recommended for person sorry, 18 years of age and older in the u.s. population. >> under the fda's emergency use authorization. >> in the meantime, the white house says it's planning to step up its effort to get millions of more people vaccinated. we have less of a supply we have more of a. it's incumbent upon us to reach people in need them where they are. we are laser focused on educating the public at a white house covid response briefing friday lead coordinator. jeffrey zients seemingly acknowledged after weeks of steady vaccination. daily numbers. the nation saw a recent dip going forward. we expect daily vaccination rates will moderate and fluctuate. he says the administration is pouring millions of dollars to reach people less eager to get vaccinated, including encouraging walk-up availability and providing transportation options. i'm concerned. illinois senator durbin says he hope

a cdc advisory panel recommending the u.s. resume using johnson & johnson's covid vaccines but with an added warning label. cdc advisers finding the benefits of the single-shot vaccine outweigh the risk of rare blood clots it comes after the cdc said it was aware of more clotting cases, 15 now in total, and three deaths, all in women, most under 50 will americans accept the risk and how soon could the shots be going into arms again >>> new developments in the police shooting of a black father of three deputies resigning and what protesters are demanding. >>> the race against time to find a missing submarine with 53 crew members before oxygen runs out the u.s. joining the effort and what was detected in the water today >>> the historic spacex launch. the first manned mission on a recycled capsule and rocket plus, what sent the astronauts aboard scrambling today >>> the price you pay for home improvements soaring. what you need to know before you start that project. >>> our kristen welker opening up about her journey with mother

. >> reporter: a cdc advisory panel tonight says it needs more time and information to respond to the new concerns about the johnson & johnson vaccine. which means for now, americans should continue holding off using this brand of the covid vaccine. >> we do not have to arrive at a vote today or a recommendation today. if we need more time to think about this, we can reconvene later this week or this weekend >> reporter: a very small number of women who suffered blood clots after getting the shot caused health officials to put a hold on using the drug. health officials here worry that this potential adverse reaction looks a little too similar to what happened in europe with the astrazeneca vaccine. the astrazeneca vaccine is made using similar technology as the johnson & johnson, and in europe 19 people died. >> there are some rather strong similarities about this with regard to the time frame following vaccination. particularly importantly, the clinical syndrome of these clots together with low platelets. so there are a lot of similarities there that you just can't miss that. >> repo

a cdc advisory panel recommending the u.s.esume using johnson & johnson's covid vaccines but with an added warning label. cdc advisers finding the benefits of the single-shot vaccine outweigh the risk of rare blood clots it comes after the cdc said it was aware of more clotting cases, 15 now in total, and three deaths, all in women, most under 50 will americans accept the risk and how soon could the shots be going into arms again >>> new developments in the police shooting of a black father of three deputies resigning and what protesters are demanding. >>> the race against

plus j&j shares closing higher ahead of the cdc advisory panel's decision on its covid vaccine pause.as it's released. chris ver rone from strat gus partners is still with us as is sylvia jab lonsky. and joined now by courtney gibson from luke capital as well christopher, just on that sort of finish there we talked about the sort of highs of the session when you joined us obviously closing off those. negative week. but decent end to the week regardless >> decent end to the week. little best a curious week you saw this rotation back to risk sitting at about 155, 160 range where they've button last two weeks. what we're trying to figure out here is how much good news is already priced into this market and does the contraction in bond yields over the last few weeks, reflect the idea we might be approaching peak data? and i think that's a consideration investors are going to have to think about over the coming weeks. this collision between expectations and reality it is very easy to exceed expectations the first year off a low. that gets more dhaji ingchallens the market cycle matures. >>

the cdc advisory panel says it needs more time to assess the data and the risks from the j&j vaccine after a seventh woman developed these very rare blood clots, seven women out of 7 million shots. the cdc advisory panel says it needs a week to ten days to look at all of this information, and so for now the j&j vaccine remains on pause at vaccine distribution sites like this drive-up clinic in pittsburgh, staffers are now swapping their johnson & johnson doses for pfizer and moderna shots as the head of the cdc seeks to reassure the public those vaccines which use a different technology than j&j are safe. >> these types of reactions, blood clots in combination with low platelets are not being seen with the authorized vaccines from pfizer and moderna. >> this is all the johnson & johnson that i can't use >> reporter: the chief scientific officer at johnson & johnson in a statement says the safety and well-being of the people who use our products is our number one priority, adding we continue to believe in the positive benefit/risk profile of our vaccine. even in the unlikely event tha

blood platelets after their shot several became seriously ill and 3 died all women but the expert advisory panel and health officials concluded the benefits of the vaccine outweighed the risks and that new guidance for doctors could help mitigate any damage we found that for every 1000000 doses of this vaccine the james j. vaccine could prevent over 650 hospitalizations and well deaths among women aged 18 to 40 and this vaccine could prevent over 4700 hospitalizations and nearly 600 deaths among women over unlike the pfizer and moderna vaccines johnson and johnson's version doesn't require a 2nd dose and it can be transported without deep freeze storage j.n.j. and important docs in offering key advantages including its single does option and its viability when the supply chain may not allow for answers health officials say administering johnson and johnson. vaccine will resume almost immediately likely as soon as saturday robert oulds al jazeera los angeles. leaders from southeast asia are preparing for crisis talks with me and miles military ruler general min on line the will attend the 10 nati

while european officials are recommending a warning, back here in the u.s., the cdc advisory panel is expected to meet again on friday. david? >> all right, marcus moore tonight with us, as well. thank you. >>> when we come back here, there is news this evening about another deadly shooting. this time, at a grocery store right outside new york city. the unfolding scene today. >>> and later tonight, we remember a former vice president. if you have obstructive sleep apnea and you're often tired during the day, you could be missing out on amazing things. sunosi can help you stay awake for them. once daily sunosi improves wakefulness in adults with excessive daytime sleepiness due to obstructive sleep apnea. continue to use any treatments tor devices as prescribed inby your doctor.dy.notrcf don't take sunosi if you've taken an maoi in the last 14 days. sunosi may increase blood pressure and heart rate, which can increase your risk of heart attack, stroke, heart failure, or death. tell your doctor if you have a heart condition or high blood pressure. sunosi can cause symptoms such as anxie

as a cdc advisory panel prepares to meet on friday about johnson and johnson vaccine, the family of 18-year-old emma burkey identifying her as one of six women out of 7 million people vaccinated with j&j who suffered extremely rare blood clots. it's unclear if the vaccine is responsible. emma was hospitalized on a ventilator, but is slowly recovering. >> emma's likely going to have to learn to relearn to walk, relearn to speak, all of those things. >> reporter: even with the challenges ahead, emma's family wants americans to get a vaccine. >> they see this as just a, you know, a one in a million situation. they feel strongly that people should get vaccinated and not use this as an excuse or a reason for fear. >> reporter: the number of americans getting their first dose of the covid vac seep has been dropping for several days now. just to give you an example, david, on friday, the u.s. was averaging 3 pn.35 million shots day total and today we're averaging just over 3 million. david? >> all right, stephanie ramos with us tonight. steph, thank you. >>> and we do have one more important

i listened to hours of discussion among the advisory panel to the c.d.c.as blown away by the depth of discussion, the seriousnpe these are some of the smartest people on the planet discussing the problem in a completely transparent way with anyone who wants to listen able to do so. and to me, norah, that is a formula for boosting confidence. >> o'donnell: yeah, so much transparency. all right, dr. jon lapook, thank you. and now to this story. millions of americans from texas to florida and the carolinas are facing the threat of severe storms this weekend. tonight, the southern plains could be hit with tornadoes and hail. let's get the forecast now from cbs' lonnie quinn. good evening, lonnie. >> reporter: good evening, norah. good evening, everyone. look, it's getting to be that time of the year. you see these severe weather outbreaks. i want to show you right now where the toughest weather is. you take a look around dallas, a in louisiana, torno wah.thatxa r is lighting up. there's a strong line on top of interstate 45 that is moving into louisiana. that

this after a cdc advisory panel extended a pause on the johnson & johnson vaccine to investigate rare blood clots in six women. the fallout swift. some vaccination sites already seeing a dip in demand. >> it's pretty unfortunate, because there's so much fear about the vaccines already. >> reporter: many of the 7,000 locations that were only offering johnson & johnson now scrambling to make other vaccines available. but the extended pause getting pushback from some health experts worried about vaccine confidence. >> if it comes to be that there are people who don't get a vaccine because they were only going to get the johnson & johnson vaccine or don't get covid vaccines in general, then we've done harm. then we haven't exercised caution, and in the name of caution we've actually put people in a riskier situation. >> the picture across the nation. whit, you reported pfizer ceo predicting americans might need a third shot within a year, a booster after being vaccinated. and i know tonight there's new data out on how many people have been infected with the virus after being vaccinated, a

reporter: any future use of the johnson & johnson covid vaccine could be decided tomorrow by a cdc advisory panel. because it's a single shot, it's become an important tool in fighting the coronavirus. >> we need to make a decision quickly i'm and really hopeful that we'll be able to use the vaccine soon. >> reporter: u.s. health officials put use of the vaccine on hold after six women developed rare blood clots after getting the shot. tomorrow, they could continue with that hold or join health officials in europe, who just days ago decided that the benefits outweigh the risks and have cleared the vaccine to be used with a safety warning. across the country, it appears fewer people are rushing to get immunized, with thousands of appointments sitting empty and some vaccination places shutting down. >> when 16 and older opened, i did expect a rush and it just never materialized. >> reporter: for the first time in weeks, the daily average of shots put into arms has fallen below 3 million doses a day. >> obviously there is an element of vaccine hesitancy or concern that we need to address. >> reporte

having weighed the evidence, an advisory panel voted to give johnson &johnson a shot in the arm.iew of the available data, the fda and cdc are lifting the recommended pause on the johnson &johnson, orjanssen, covid—19 vaccine. the pause was recommended due to a number of adverse events recorded after the janssen covid—19 vaccine was administered. those adverse events amount to blood clots, reported by a total of 15 women who'd received thejohnson & johnson vaccine, three of whom subsequently died. but more than seven million doses of the vaccine had been administered before distribution was suspended 11 days ago, and health officials believe the benefits outweigh the risks. they've declared the single—shot vaccine safe and effective in combating covid—i9. as of this past sunday, more than 50% of adult americans have had at least one vaccine shot. we still have a long way to go, but that's an important marker of progress. president biden had set the 4th ofjuly, america's birthday, as a goal for getting this country back to normal, and although the pfizer and moderna vaccines have

when a cdc advisory panel meets on friday >> announcer: this is "nbc nightly news" with lester holt >>> good evening former police officer derek chauvin walked out of a minneapolis courtroom in handcuffs this afternoon, minutes after a jury convicted him on all counts in the death of george floyd. second-degree unintentional murder, guilty third-degree murder, guilty. second-degree manslaughter, guilty a world that witnessed video of floyd's death under the knee of that police officer today witnessing justice for mr. floyd. president biden and vice president harris calling the floyd family tonight, expressing their satisfaction with the verdict and speaking to the nation this evening as well. a day of intense emotion we want to begin our coverage now with gabe gutierrez. >> reporter: tonight, emotions are spilling into the streets of minneapolis. people cried as the verdict was read >> i can't believe it. there's poetry in the fact he couldn't breathe and it feels like we got a breath of fresh air. for the first time, it feels like we can breathe. >> it was just a beautiful moment whe

and advisory panel is set to me it again friday to consider the fate of the one dose vaccine. >>> todaynterviewed doctor webb, a senior advisor on the white house response team and i asked him what exact fully the 200 million does milestone means in terms of immunity and getting past this pandemic. >> we have made quite a bit of progress in these last few weeks but it also means we still have a lot le to do and over 5 who havehad at least one shot and just over one third who are the full course in which is great news but we have a lot of work to go. >> how big of a setback is the johnson & johnson issue pausing the use of that vaccine in the u.s.? >> i don't think it is as much of a setback as it is a moment for us to show our commitment to safety and a moment for us to show that even when you have six incidents of this really rare complication out of 7 million shots that is still a moment for us to pause and make sure we do our due diligence and we follow the science. i think that is the big dynamic there. in terms of vaccine availability between pfizer and moderna we do have enough va

. >>> citing an urgent need to get the country vaccinated, ac/dc advisory panel recommends resuming thethanks for joining us, i am dan ashley. >> it is up to dr. rochelle walensky to sign off. when that happens, vaccination using the j&j vaccine could resume within a matter of hours. stephanie sierra has been keeping an eye on this all day. she joins us live from the newsroom. >> reporter: the vote was tense with one person who declined to vote. johnson & johnson was put on hold after reports of severe but rare blood clots formed in women, particularly those under the age of 50. today, there are 15 known cases out of the 8 million doses that have been administered in the u.s. women, half of them are in their 30s. symptoms typically started a week or two after receiving the vaccine. a doctor at today's meeting said the clotting disorder is quite rare, but clinically serious. at least a dozen of them involved clots forming in the brain. the cdc is planning a briefing next week where it will lay out the symptoms and treatments that are associated with the clotting disorder. >> the cdc in p

having weighed the evidence, and advisory panel voted j evidence, and advisory panel voted to givejohnsonot in the arm. ., ., . . to give johnson &johnson a shot in the arm. ., ._ ., ., , the arm. today, after an extensive review of the _ the arm. today, after an extensive review of the available data, - the arm. today, after an extensive review of the available data, the i review of the available data, the fda and cdc are lifting the recommended pause on thejohnson & johnson orjansen covid—i9 vaccine. the pause is recommended due to a number of adverse events recorded after the janssen covid—i9 vaccine was administered. after the janssen covid-19 vaccine was administered.— was administered. those address events amount _ was administered. those address events amount to _ was administered. those address events amount to blood - was administered. those address events amount to blood clots, . events amount to blood clots, reported by a total of 15 women who had received thejohnson &johnson vaccine, three of whom subsequently died. but more than 7 million doses of the vaccine had been adminis

a cdc advisory panel looking into those rare cases of blood clots deciding to hold off on making a decisionut using the vaccine until they have more information. several doctors on the panel saying they were not comfortable lifting the pause just yet. >> i'm definitely in favor of a pause because the true incidence of this condition may be revealed now that we've had so many more doses administered. >> and by having a little more robust information, i think we can be much more confident in how we talk about the safety of this vaccine. >> reporter: the rare blood clots reported in only 6 of the nearly 7 million americans who have received the j&j one-dose vaccine. a less than 1 in a million occurrence. all six were women between 18 and 48 years old. they got sick within two weeks of getting vaccinated. some of the clots formed in the brain. it is unclear if the vaccine is responsible for those clots. while none of these patients had a known clotting disorder, three women were obese. one had high blood pressure and one had asthma. it is not known if those conditions contributed to their risk.